Humana (NYSE:HUM) experienced a 3% price increase last week, which may have been influenced by its recent partnership with Mercy to open new primary care clinics for seniors. This expansion addresses ...

Shares of Humana Inc. HUM rose 1.39% to $234.96 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.38% to 6,045.26 and the ...

Humana faces significant earnings headwinds due to CMS reforms, star rating downgrades, and potential Medicaid clawbacks.

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

Humana (NYSE:HUM) recently reported first-quarter earnings, showcasing a revenue increase from USD 29,611 million to USD 32,112 million and a net income rise from USD 741 million to USD 1,244 million.

The S&P 500 slipped less than 0.1% on Thursday, May 22, after the House narrowly passed the Republicans' "big beautiful" tax ...

Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue ... Analysts typically rate each stock once per quarter. Some analysts will also offer forecasts ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently appears ...

The company's recent financial performance has been mixed. While Humana has maintained a solid ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...